作者: Robert Kralovics , Francesco Passamonti , Andreas S. Buser , Soon-Siong Teo , Ralph Tiedt
DOI: 10.1056/NEJMOA051113
关键词: Immunology 、 Janus kinase 2 、 Myeloproliferative Disorders 、 TG101348 、 Myelofibrosis 、 Ruxolitinib 、 Medicine 、 Cancer research 、 Essential thrombocythemia 、 Myeloproliferative neoplasm 、 Polycythemia vera
摘要: background Polycythemia vera, essential thrombocythemia, and idiopathic myelofibrosis are clonal myeloproliferative disorders arising from a multipotent progenitor. The loss of heterozygosity (LOH) on the short arm chromosome 9 (9pLOH) in suggests that 9p harbors mutation contributes to cause expansion hematopoietic cells these diseases. methods We performed microsatellite mapping 9pLOH region DNA sequencing 244 patients with (128 polycythemia 93 23 myelofibrosis). results Microsatellite identified included Janus kinase 2 ( JAK2 )